Year: 2011
Type: article
Abstract: Alterations of epigenetic marks have an important role in myeloid malignancies. 1 Mutations have been found in several epigenetic regulators including ASXL1, DNMT3A, EZH2, IDH1/2 and TET2. 2 , 3 DNMT3A, IDH1/2 and TET2 are involved in the regulation of DNA methylation. EZH2 belongs to a complex of proteins called ‘polycomb repressor complex 2’ (PRC2). 4 ASXL1 is a regulator of PRC1, the other polycomb complex. Several other proteins belong to the two polycomb complexes; although alterations of ASXL1 5 and EZH2 6 , 7 are probably prominent in myeloid diseases, we suspected that these other PRC components might also be involved in some cases.
Source: Blood Cancer Journal
DOI: 10.1038/bcj.2011.31
Language: English
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Open Access status: gold
Estimated APC paid: $5,290
OpenAlex ID: W1976212321
